Vitru

Vitru Equity

Delisted

The The Equity of Vitru (VTRU) as of Oct 20, 2026 is 2.28 B BRL. In the previous year, The Equity was 2.17 B BRL — a change of 5.07% (higher).

Equity

2.28 BBRL

YoY

5.07%

Last updated:

In 2023, Vitru's equity was 2.28 B BRL, a 5.07% increase from the 2.17 B BRL equity in the previous year.

The Vitru Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
519.40 M BRL
Jan 1, 2019
451.30 M BRL
Jan 1, 2020
977.90 M BRL
Jan 1, 2021
1.07 B BRL
Jan 1, 2022
2.17 B BRL
Jan 1, 2023
2.28 B BRL
The Vitru Equity history
YEAREquityYoY
2.28 BBRL+5.07%
2.17 BBRL+103.96%
1.07 BBRL+9.02%
977.90 MBRL+116.69%
451.30 MBRL-13.11%
519.40 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitru Stock analysis

What does Vitru do? Vitru Ltd is a British company specializing in the production and sale of high-quality and innovative implants and medical devices. The company was founded in 2011 and is based in London. Its initial focus was on developing products for human body reconstruction, including implants for knees, hips, and shoulders, as well as products for tendon and ligament repair. Vitru produces high-quality products that meet the highest standards by using state-of-the-art technologies and materials. The company has quickly become a leading provider in this market and continues to expand its offerings and expertise. This includes not only the manufacturing of implants but also the development and production of instruments and procedures that enable more precise and efficient surgeries for doctors and surgeons. Vitru also offers products and services in the areas of phenotyping and genotyping, collecting data on a person's genetic characteristics and using that information for personalized medicine and diagnostics. Another business field of Vitru is 3D printing. By utilizing 3D printing technology, the company can rapidly manufacture products and better meet customer needs. Vitru offers a wide range of implants that can be customized to individual customer requirements. In this context, Vitru has also engaged in the production of masks and other facial protection products to contribute to the fight against the COVID-19 pandemic. Vitru's products are known for their high quality, durability, and functionality. They are distributed both in the UK and worldwide and are used in orthopedics, neurosurgery, and other medical specialties. The company has a clear mission to be a global leader in the development and manufacturing of medical devices and implants tailored to the needs of patients and surgeons. To fulfill this mission, Vitru collaborates closely with professionals in the fields of medicine and technology. The company also works closely with hospitals and research institutions to stay up to date with the latest developments in medicine and technology and incorporate them into its products. An example of this is the development of knee implants specifically designed for women to better accommodate their needs. Overall, Vitru has established itself as an important player in the medical technology industry and is committed to improving healthcare for patients worldwide. Vitru is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Vitru's Equity

Vitru's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vitru's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vitru's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vitru's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vitru’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vitru stock

The Equity of Vitru is 2.28 B BRL in 2023.

The Equity of Vitru changed from 2.17 B BRL to 2.28 B BRL, representing a 5.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Vitru since 2006 – with annual values, charts, and detailed analysis.

The Equity's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Vitru historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Vitru

All Key Metrics — Vitru